Everyone seems to agree: Drug prices are too damn high. Scandalous prices for new drugs and enormous price hikes on old drugs have focused public ire on the pharmaceutical industry. A bipartisan consensus has emerged that something must be done to tackle
Read More...
Read the complete post at http://healthaffairs.org/blog/2017/04/27/value-based-pricing-for-pharmaceuticals-in-the-trump-administration/
Posted
Apr 27 2017, 10:15 AM
by
Health Affairs BlogHealth Affairs Blog